Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study
暂无分享,去创建一个
V. Gushchin | A. Gintsburg | S. Fitilev | A. Tkachuk | D. Vasina | V. Chulanov | L. Popova | E. Smolyarchuk | D. Kleymenov | V. Manuylov | M. Semashko | E. Bykonia | Semyon L Maksimov | D. A. Kleymenov